Product How it works Pricing Blog FAQ About Contact
C4 Therapeutics

C4 Therapeutics (NASDAQ: CCCC) revenue

C4 Therapeutics reported revenue of $35.9m for fiscal 2025, 1.0% more than in fiscal 2024 ($35.6m). Since fiscal 2021 its revenue has fallen by 21.5%, an average decline of 5.9% a year.

C4 Therapeutics has grown its revenue for 2 years in a row, and its best year of the last 5 was fiscal 2021. The biggest drop was in fiscal 2023, −33.3%.

Revenue, in millions of US dollars45.8202131.1202220.8202335.6202435.92025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$35.9m+1.0%−$115.2m−320.5%
2024$35.6m+71.4%−$119.6m−336.1%
2023$20.8m−33.3%−$139.0m−669.8%
2022$31.1m−32.1%−$129.5m−416.6%
2021$45.8m—−$82.1m−179.4%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

C4 Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, C4 Therapeutics ranks 343rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; C4 Therapeutics, 1.0%.

RankCompanyRevenueRevenue growth
341stUtah Medical Products$38.5m−5.8%
342ndClearPoint Neuro$37.0m17.8%
343rdC4 Therapeutics$35.9m1.0%
344thSenseonics$35.3m56.9%
345thX4 Pharmaceuticals$35.1m1,250.5%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of C4 Therapeutics

How much revenue did C4 Therapeutics make in fiscal 2025?
C4 Therapeutics reported revenue of $35.9m for fiscal 2025, compared with $35.6m in fiscal 2024.
How much has the revenue of C4 Therapeutics fallen?
Between fiscal 2021 and fiscal 2025 it went from $45.8m to $35.9m: 21.5% less, an average decline of 5.9% a year.
What was the best year for revenue at C4 Therapeutics?
Of its last 5 fiscal years, fiscal 2021, with $45.8m.
Where does C4 Therapeutics rank in its sector by revenue?
It ranks 343rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for C4 Therapeutics come from?
From the annual report (Form 10-K) that C4 Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that C4 Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on C4 Therapeutics: the C4 Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.